Cleared Traditional

K933269 - AIA-PACK PROG ASSAY

K933269 is the FDA 510(k) clearance for AIA-PACK PROG ASSAY by Tosoh Medics, Inc.. It is a Class 1 Chemistry device (product code JLS) cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K933269 · Tosoh Medics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1993
Decision
108d
Days
Class 1
Risk

K933269 is an FDA 510(k) clearance for the AIA-PACK(R) PROG ASSAY. Classified as Radioimmunoassay, Progesterone (product code JLS), Class I - General Controls.

Submitted by Tosoh Medics, Inc. (Foster City, US). The FDA issued a Cleared decision on October 22, 1993 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1620 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Tosoh Medics, Inc. devices

Submission Details

510(k) Number K933269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 1993
Decision Date October 22, 1993
Days to Decision 108 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 88d · This submission: 108d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JLS Radioimmunoassay, Progesterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1620
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JLS Radioimmunoassay, Progesterone

All 31
Devices cleared under the same product code (JLS) and FDA review panel - the closest regulatory comparables to K933269.
IMMULITE PROGESTERONE
K935138 · Diagnostic Products Corp. · Jan 1994
SYNELISA PROGESTERONE
K933128 · Elias U.S.A., Inc. · Nov 1993
PROGESTERONE RADIOIMMUNOASSAY KIT
K931228 · Immunotech Corp. · Oct 1993
STRATUS PROGESTERONE FLOUROMETRIC IMMUNOASSAY
K933635 · Baxter Diagnostics, Inc. · Oct 1993
CIBA CORNING ACS PROGESTERONE IMMUNOASSAY
K932955 · Ciba Corning Diagnostics Corp. · Aug 1993
AFFINITY PRG
K920230 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Feb 1992